97 related articles for article (PubMed ID: 14557648)
1. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1.
Carter JJ; Wipf GC; Benki SF; Christensen ND; Galloway DA
J Virol; 2003 Nov; 77(21):11625-32. PubMed ID: 14557648
[TBL] [Abstract][Full Text] [Related]
2. A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5.
Xia L; Xian Y; Wang D; Chen Y; Huang X; Bi X; Yu H; Fu Z; Liu X; Li S; An Z; Luo W; Zhao Q; Xia N
Sci Rep; 2016 Jan; 6():19042. PubMed ID: 26750243
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an RNA aptamer against HPV-16 L1 virus-like particles.
Leija-Montoya AG; Benítez-Hess ML; Toscano-Garibay JD; Alvarez-Salas LM
Nucleic Acid Ther; 2014 Oct; 24(5):344-55. PubMed ID: 25111024
[TBL] [Abstract][Full Text] [Related]
4. Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates.
Pradini GW; Sahiratmadja E; Suhandono S; Sudigdoadi S; Yusuf M; Firdaus ARR; Susanto H
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2517-2523. PubMed ID: 32986347
[TBL] [Abstract][Full Text] [Related]
5. The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein.
Dehghani B; Hasanshahi Z; Hashempour T; Motamedifar M
Biologia (Bratisl); 2020; 75(5):749-759. PubMed ID: 32435064
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Human Papillomavirus-16 Virus-like Particles Presenting HIV-1 P18I10 Peptide: Expression, Purification, Bio-Physical Properties and Immunogenicity in BALB/c Mice.
Chen CW; Saubi N; Joseph-Munné J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175776
[TBL] [Abstract][Full Text] [Related]
7. Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas.
Tsakogiannis D; Nikolaidis M; Zagouri F; Zografos E; Kottaridi C; Kyriakopoulou Z; Tzioga L; Markoulatos P; Amoutzias GD; Bletsa G
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680181
[TBL] [Abstract][Full Text] [Related]
8. Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice.
Chen CW; Saubi N; Kilpeläinen A; Joseph-Munné J
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679860
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies.
Godi A; Vaghadia S; Cocuzza C; Miller E; Beddows S
Microbiol Spectr; 2022 Jun; 10(3):e0077922. PubMed ID: 35475682
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of binding.
He M; Chi X; Zha Z; Li Y; Chen J; Huang Y; Huang S; Yu M; Wang Z; Song S; Liu X; Wei S; Li Z; Li T; Wang Y; Yu H; Zhao Q; Zhang J; Zheng Q; Gu Y; Li S; Xia N
J Virol; 2021 Mar; 95(7):. PubMed ID: 33472937
[TBL] [Abstract][Full Text] [Related]
11. Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity.
Chabeda A; van Zyl AR; Rybicki EP; Hitzeroth II
Front Plant Sci; 2019; 10():779. PubMed ID: 31281327
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.
Balanda M; Fernández J; Vergara N; Campano C; Arata L; Martín HS; Ramírez E
Med Microbiol Immunol; 2019 Dec; 208(6):757-771. PubMed ID: 31165237
[TBL] [Abstract][Full Text] [Related]
13. Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity.
Li Z; Song S; He M; Wang D; Shi J; Liu X; Li Y; Chi X; Wei S; Yang Y; Wang Z; Li J; Qian H; Yu H; Zheng Q; Yan X; Zhao Q; Zhang J; Gu Y; Li S; Xia N
Nat Commun; 2018 Dec; 9(1):5360. PubMed ID: 30560935
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.
Becker M; Greune L; Schmidt MA; Schelhaas M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593032
[TBL] [Abstract][Full Text] [Related]
15. High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.
Guan J; Bywaters SM; Brendle SA; Ashley RE; Makhov AM; Conway JF; Christensen ND; Hafenstein S
Viruses; 2017 Dec; 9(12):. PubMed ID: 29211035
[TBL] [Abstract][Full Text] [Related]
16. Naturally occurring capsid protein variants L1 of human papillomavirus genotype 16 in Morocco.
El-Aliani A; Alaoui MAE; Chaoui I; Ennaji MM; Attaleb M; Mzibri ME
Bioinformation; 2017; 13(8):241-248. PubMed ID: 28959092
[TBL] [Abstract][Full Text] [Related]
17. Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus.
Li Z; Wang D; Gu Y; Song S; He M; Shi J; Liu X; Wei S; Li J; Yu H; Zheng Q; Yan X; Baker TS; Zhang J; McLellan JS; Li S; Xia N
mBio; 2017 Sep; 8(5):. PubMed ID: 28951471
[TBL] [Abstract][Full Text] [Related]
18. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
[TBL] [Abstract][Full Text] [Related]
19. The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.
Bissett SL; Godi A; Beddows S
Sci Rep; 2016 Dec; 6():39730. PubMed ID: 28004837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
